Consentement d'utilisation des Cookies

J'accepte. Notre site sauvegarde des traceurs textes (cookies) sur votre appareil afin de vous garantir de meilleurs contenus et à des fins de collectes statistiques.Vous pouvez désactiver l'usage des cookies en changeant les paramètres de votre navigateur. En poursuivant votre navigation sur notre site sans changer vos paramètres de navigateur vous nous accordez la permission de conserver des informations sur votre appareil.

89-73-6 - Salicylhydroxamic acid, 99% - 2-Hydroxybenzohydroxamic acid - A11528 - Alfa Aesar

A11528 Salicylhydroxamic acid, 99%

Numéro de CAS
89-73-6
Synonymes
2-Hydroxybenzohydroxamic acid

Conditionnement Prix ($) Quantité Disponibilité
10g 25,20
25g 47,00
50g 82,70
100g 155,00
Ajouter au panier Ajouter au devis en vrac Afficher l'article

Salicylhydroxamic acid, 99%

MDL
MFCD00002110
EINECS
201-934-3

Propriétés chimiques

Formule
C7H7NO3
Poids moleculaire
153.14
Point de fusion
ca 170° dec.
Solubilité
It is soluble in water.

Applications

It is widely used for a variety of roles in biology and medicine as a chelating therapy. It inhibits bacterial or fungi growth by interfering with iron uptake. It is also active as a inhibitor of enzyme involved in tumour growths. These compounds are used as extractants for the separation of valuable metals or minerals including copper, lead, gold, other rare earth metals and kaolin. Hydroxamic acids are also used to produce corresponding isocyanates by dehydration followed by rearrangement reaction. It is also used as a common ligand utilized in the synthesis of metallacrowns.

Notes

Store in cool place. Keep container tightly closed in a dry and well-ventilated place. Incompatible to Strong bases. Stable under normal conditions.

Références bibliographiques

Curt A. Davey & Roger E. Fenna. 2.3 Å Resolution X-ray Crystal Structure of the Bisubstrate Analogue Inhibitor Salicylhydroxamic Acid Bound to Human Myeloperoxidase:? A Model for a Prereaction Complex with Hydrogen Peroxide. Biochemistry. 1996, 35, (33), 10967-10973.

Mark L. Stolowitz.; Clarence Ahlem.; Karin A. Hughes.; Robert J. Kaiser.; Edward A. Kesicki.; Guisheng Li.; Kevin P. Lund.; Steven M. Torkelson.; and Jean P. Wiley. Phenylboronic Acid-Salicylhydroxamic Acid Bioconjugates. 1. A Novel Boronic Acid Complex for Protein Immobilization. Bioconjugate Chem. 2001, 12, (2), 229-239.

Mentions de danger et de prudence du SGH

Mentions de danger (UE): H303-H315-H319-H341-H335

May be harmful if swallowed. Causes skin irritation. Causes serious eye irritation. Suspected of causing genetic defects. May cause respiratory irritation.

Mentions de prudence: P201-P261-P280-P305+P351+P338-P405-P501a

Obtain special instructions before use. Avoid breathing dust/fume/gas/mist/vapours/spray. Wear protective gloves/protective clothing/eye protection/face protection. IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing. Store locked up. Dispose of contents/container in accordance with local/regional/national/international regulations.

Autres références

Merck
14,8331
Beilstein
1210520
Code tarifaire harmonisé
2928.00
TSCA
No
RTECS
VO6870000

Recommandé

Consulté récemment

Produits chimiques

Sciences de la vie

Métaux et matériaux

Catalyseurs

Analytique et matériel de laboratoire